AAAAAA

   
Results: 1-7 |
Results: 7
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients
Authors: Venkataramanan, R Shaw, LM Sarkozi, L Mullins, R Pirsch, J MacFarlane, G Scheller, D Ersfeld, D Frick, M Fitzsimmons, WE Virji, M Jain, A Brayman, KL Shaked, A
Citation: R. Venkataramanan et al., Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients, J CLIN PHAR, 41(5), 2001, pp. 542-551
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: Three-year follow-up
Authors: Pescovitz, M Conti, D Greenstein, SM Inokuchi, S Rosenthal, J Cohen, D Stiller, C Pirsch, J Tomlanovich, S Cho, S Deierhoi, M Ferguson, R Gonwa, T Hodge, E Keown, PA Ramos, E Navarro, MT
Citation: M. Pescovitz et al., Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: Three-year follow-up, TRANSPLANT, 71(8), 2001, pp. 1091-1097
Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: Pharmacokinetics and tolerability
Authors: Pirsch, J Bekersky, I Vincenti, F Boswell, G Woodle, ES Alak, A Kruelle, M Fass, N Facklam, D Mekki, Q
Citation: J. Pirsch et al., Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: Pharmacokinetics and tolerability, J CLIN PHAR, 40(5), 2000, pp. 527-532
Valganciclovir results in improved oral absorption of ganciclovir in livertransplant recipients
Authors: Pescovitz, MD Rabkin, J Merion, RM Paya, CV Pirsch, J Freeman, RB O'Grady, J Robinson, C To, Z Wren, K Banken, L Buhles, W Brown, F
Citation: Md. Pescovitz et al., Valganciclovir results in improved oral absorption of ganciclovir in livertransplant recipients, ANTIM AG CH, 44(10), 2000, pp. 2811-2815
Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients
Authors: Curtis, JJ Barbeito, R Pirsch, J Lewis, RM Van Buren, DH Choudhury, S
Citation: Jj. Curtis et al., Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients, AM J KIDNEY, 34(5), 1999, pp. 869-874
Utilization of pediatric donors for pancreas transplantation
Authors: Van der Werf, WJ Odorico, J D'Alessandro, AM Knechtle, S Becker, Y Collins, B Pirsch, J Hoffman, R Sollinger, HW
Citation: Wj. Van Der Werf et al., Utilization of pediatric donors for pancreas transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 610-611
Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
Authors: Ahsan, N Hricik, D Matas, A Rose, S Tomlanovich, S Wilkinson, A Ewell, M McIntosh, M Stablein, D Hodge, E Hayes, D Gores, P Cohen, D Gonwa, T Brinler, K Harland, R Neylan, J Pescovitz, M Wynn, J Ahsan, N Yang, HC Bennett, W Copley, J Wilkinson, A Dunn, J Tomlanovich, S Chan, L Bertolatus, JA Weir, M Mendez, R Pirsch, J Helderman, JH
Citation: N. Ahsan et al., Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study, TRANSPLANT, 68(12), 1999, pp. 1865-1874
Risultati: 1-7 |